|4Jun 13, 4:43 PM ET

ENDRA Life Sciences Inc. 4

4 · ENDRA Life Sciences Inc. · Filed Jun 13, 2017

Insider Transaction Report

Form 4
Period: 2017-06-09
Michelon Francois Roger
DirectorChief Executive Officer
Transactions
  • Award

    Stock Options

    2017-06-09+31,96031,960 total
    Exercise: $4.55Exp: 2022-05-12Common Stock (31,960 underlying)
Footnotes (1)
  • [F1]These Stock Options become exercisable in three equal annual installments beginning on May 12, 2018.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION